TrivarX Limited
MDBIF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 27% | -7.5% | -4.5% | – |
| Cost of Goods Sold | $0 | $0 | $1 | $0 |
| Gross Profit | $1 | -$0 | -$1 | $1 |
| % Margin | 100% | -10.5% | -120.2% | 99.9% |
| R&D Expenses | $0 | $0 | $0 | $1 |
| G&A Expenses | $0 | $0 | $1 | $1 |
| SG&A Expenses | $1 | $2 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$1 |
| Operating Expenses | $1 | $2 | $2 | $2 |
| Operating Income | $0 | -$2 | $0 | -$1 |
| % Margin | 11.4% | -238.2% | 1.9% | -50.1% |
| Other Income/Exp. Net | -$1 | $1 | -$3 | -$12 |
| Pre-Tax Income | -$1 | -$1 | -$3 | -$13 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$1 | -$3 | -$13 |
| % Margin | -83.5% | -139.2% | -319.7% | -1,264.7% |
| EPS | -0.002 | -0.004 | -0.017 | -0.12 |
| % Growth | 52.5% | 76.9% | 85.6% | – |
| EPS Diluted | -0.002 | -0.004 | -0.017 | -0.12 |
| Weighted Avg Shares Out | 496 | 309 | 178 | 103 |
| Weighted Avg Shares Out Dil | 496 | 309 | 178 | 103 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $1 | $0 |
| EBITDA | -$1 | -$1 | -$3 | -$3 |
| % Margin | -75.9% | -149.9% | -262.3% | -257% |